Today genting macam will rebound..

@goldentriangle always so positive.

One thing I remember last time was after mother share tumbled, warrant stay high premium very long. Then one day mother share drop a lot, then fulamak, warrant play catchup to 0.5x. There is lag time. Once confidence crumbled, warrant as usual, suicide squad.

Haha. The premium now is very high but strong buy queue still there. I start to observe it closely ad. Unless got another big shock, I think this support will be there. Look see look see ba

Genting-wa my first purchase was rm1.5 then it dropped until around 0.5x. I hold and top up all the way from 0.5x to rm2.2x. Those were the good days. Haha

Actually, if buy below 8.3, current loss should be still very manageable isn't it. My rule of thumb, 10%

Read the announcement on 26july. They got mention about the Proposed Monetization Plan. They can sell for you for a fee. All details there.

4.43 and 4.44 battle very long already.

Hahaha. They need pai ang kong liau

Lols. Taurx genting HK. Auntie die bus overturn all you say one. C liau also all you say one.

I already switched to other stocks last week. See how low it can go. Btw, brexit was different. It was affecting whole market eventhough in some sense, genting UK is exposed. Now the news with genting is affecting them only mostly.

Looks like heavy bleeding here.

Anyway, it is below 20SMA now already. Monday if still down. Then, know ad kelong liau.

8.2 breached. Next support 8.0 physiological support. See closing can be above 8.2 or not ba.

Panic on WA gonna struck soon

I concurred it was a trap. From news about NASDAQ listing etc. They already knew how things will go earlier.

Next support 8.2

No more catalyst. Can't ad

True. Time to move on.

hng, what do you think of this stock?

It is surprising they din't conduct third trial as monotheraphy isn't it.

I think based on in their announcement, they are going to need another 1 or 2 years to commercialize the medicine. They dint achieve their primary goals in the research. What they said yesterday was, oh, we failed, but we found something new. Hence, we think we can further study it.

Macam gonna open in red from the queue

Let see ba. There is way for sure. I also keeping my finger cross.

I think have to be cautious. Still holding mine but there is posibbility it will will give up all gain and back to rm8 like I mentioned previously. Warrant only 1.2 to 1.3 at that price.

I think we can pretty much expect trial 0007 shows similar findings. The one with ip issue, maybe got hope.

Going up back

Some correction in my statement. Seems like patients if taking other medicine together,then it is not effective. Not that they must be a new patient. It is better than what I wrote earlier.

From what I understand so far,
Phase 2 = monotheraphy = success
Phases 3 (0015) = which is just announced showed that those taking other drugs shows no improvement. Those monotheraphy showed positive results.
Phase 3 (0005) which will be announced in 4Q, initial analysis showed similar findings like 0015. So, I think it will shows maybe like 15% of those that is taking monotheraphy finds improvement.
Phase 3 (0007) no idea.

I am not sure if that is really statistically significant but if it does get approved, the impact will be limited to new patients without any history of taking Alzheimer's medicine.

Perhaps the hard part is to convince patience, you can only take this medicine to slow down the disease. If I am FDA, I will buy the idea if they can convince me on this part.

Just my 2 cents

Huge block of sellers at 8.90. Gonna take a while to clear it.

Wait for it. Once mother share break rm9, then WA will be power back.

That is 7 Oct 2015 press release. Doesn't hint anything on latest announcement we are all waiting for.

No white Knight today? From trade pattern, looks like they are holidaying

I got mine at 1.91. Haha

There is 3 research involve in 3rd trial. Now we know one of them got delayed. One is scheduled in 4Q16. However, no mentioned of the other that is scheduled tomorrow. Forgot all the research number. But base on the news so far, they should still be presenting one of the finding tomorrow.
26/07/2016 10:45

Seems like it is difficult to break rm9.

latest news today from taurx website. one of the 3rd trial results will be delayed to next month. it does sound like they have good findings.

ABERDEEN, Scotland and Singapore, 22nd July 2016 – TauRx Therapeutics Ltd recently completed its Phase 3 clinical trial of the company’s second generation tau aggregation inhibitor, LMTX® , in behavioural variant frontotemporal dementia (bvFTD), believed to be the largest Phase 3 study ever undertaken in patients with this rare neurodegenerative disorder. Public disclosure of the study results will be delayed for a few weeks in order to permit the company to protect intellectual property arising from the on-going analysis of the patient data. The results of this trial, originally planned for presentation at the 2016 Alzheimer’s Association International Conference (AAIC) in Toronto, will now be reported for the first time at the 10th International Conference on Frontotemporal Dementias (ICFTD) in Munich on 31 August-2 September 2016.

Last minutes push up. Same pattern like March run up.

Do you find it hard to operate in a world where you have to be positive and have faith and at the same time realizing the profit? Haha

Overall, I think genting technical outlook is positive. I should be pretty safe.

Depends on mother share. If we look back, genting share price before all the movement was at around rm7. At that time, warrant was 0.8. I think that will be the worst case scenario. I used to own the warrant at 0.6cents and I don't think it will go down that low.

Yeah. I still remember there was misconception during March run-up where ppl in this forum assume the premium stay the same. Thus, they shout buy call saying the warrant has not catch up etc. Just reminding others. Haha. I now trade base on March pattern. Eg, at mother share 9.9, premium only left 0.45 cents. At Rm9, premium is around 0.9.

I don't think results will be released next week actually. I think it is more to ppl trying to get hint on how is the results during the conference.

Yes, the pattern is almost similar. Also, look at the daily and weekly chart. Look for 20 and 50-SMA crossover.

The warrant premium change with mother share price too. At current share price of 8.75, genting-wa at 1.92 is overvalued ad.

If you believe it can close at Rm9. Then can buy. If not, then exert some restrain. There will be opportunity.

I managed to collect some today at the low. Let see if got power until end of today

That is a fast u turn

Anyone managed to pick up some? I managed to

1MDB really bring bad luck liau. Support at 8.6...

1 Malaysia sueyed by 1MDB.

8.9 is support line. Steady. If suey, go back to 8.6.